06938.HK
Suzhou Ribo Life Science Co
HKSE · Healthcare · Biotechnology · CN
HKD 41.84
−2.70%Jul 2, 2026, 01:19 UTC
Ribo and Madrigal achieved the first candidate drug nomination milestone in their siRNA partnership for MASH therapies.
Source:
HKSE · Healthcare · Biotechnology · CN
Jul 2, 2026, 01:19 UTC